Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
15,024
archived clinical trials in
Infectious Disease

Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adolescents
A Phase II Study of the Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adolescents
Status: Enrolling
Updated:  2/5/2018
Clinical Research Facility
mi
from
Kingsport, TN
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adolescents
A Phase II Study of the Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adolescents
Status: Enrolling
Updated: 2/5/2018
Clinical Research Facility
mi
from
Kingsport, TN
Click here to add this to my saved trials
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adolescents
A Phase II Study of the Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adolescents
Status: Enrolling
Updated:  2/5/2018
Clinical Research Facility
mi
from
Tullahoma, TN
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adolescents
A Phase II Study of the Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adolescents
Status: Enrolling
Updated: 2/5/2018
Clinical Research Facility
mi
from
Tullahoma, TN
Click here to add this to my saved trials
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adolescents
A Phase II Study of the Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adolescents
Status: Enrolling
Updated:  2/5/2018
Clinical Research Facility
mi
from
Layton, UT
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adolescents
A Phase II Study of the Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adolescents
Status: Enrolling
Updated: 2/5/2018
Clinical Research Facility
mi
from
Layton, UT
Click here to add this to my saved trials
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adolescents
A Phase II Study of the Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adolescents
Status: Enrolling
Updated:  2/5/2018
Clinical Research Facility
mi
from
Orem, UT
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adolescents
A Phase II Study of the Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adolescents
Status: Enrolling
Updated: 2/5/2018
Clinical Research Facility
mi
from
Orem, UT
Click here to add this to my saved trials
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adolescents
A Phase II Study of the Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adolescents
Status: Enrolling
Updated:  2/5/2018
Clinical Research Facility
mi
from
Payson, UT
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adolescents
A Phase II Study of the Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adolescents
Status: Enrolling
Updated: 2/5/2018
Clinical Research Facility
mi
from
Payson, UT
Click here to add this to my saved trials
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adolescents
A Phase II Study of the Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adolescents
Status: Enrolling
Updated:  2/5/2018
Clinical Research Facility
mi
from
Provo, UT
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adolescents
A Phase II Study of the Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adolescents
Status: Enrolling
Updated: 2/5/2018
Clinical Research Facility
mi
from
Provo, UT
Click here to add this to my saved trials
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adolescents
A Phase II Study of the Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adolescents
Status: Enrolling
Updated:  2/5/2018
Clinical Research Facility
mi
from
Roy, UT
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adolescents
A Phase II Study of the Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adolescents
Status: Enrolling
Updated: 2/5/2018
Clinical Research Facility
mi
from
Roy, UT
Click here to add this to my saved trials
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adolescents
A Phase II Study of the Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adolescents
Status: Enrolling
Updated:  2/5/2018
Clinical Research Facility
mi
from
Salt Lake City, UT
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adolescents
A Phase II Study of the Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adolescents
Status: Enrolling
Updated: 2/5/2018
Clinical Research Facility
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adolescents
A Phase II Study of the Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adolescents
Status: Enrolling
Updated:  2/5/2018
Clinical Research Facility
mi
from
Salt Lake City, UT
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adolescents
A Phase II Study of the Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adolescents
Status: Enrolling
Updated: 2/5/2018
Clinical Research Facility
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adolescents
A Phase II Study of the Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adolescents
Status: Enrolling
Updated:  2/5/2018
Clinical Research Facility
mi
from
South Jordan, UT
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adolescents
A Phase II Study of the Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adolescents
Status: Enrolling
Updated: 2/5/2018
Clinical Research Facility
mi
from
South Jordan, UT
Click here to add this to my saved trials
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adolescents
A Phase II Study of the Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adolescents
Status: Enrolling
Updated:  2/5/2018
Clinical Research Facility
mi
from
Spanish Fork, UT
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adolescents
A Phase II Study of the Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adolescents
Status: Enrolling
Updated: 2/5/2018
Clinical Research Facility
mi
from
Spanish Fork, UT
Click here to add this to my saved trials
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adolescents
A Phase II Study of the Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adolescents
Status: Enrolling
Updated:  2/5/2018
Clinical Research Facility
mi
from
Syracuse, UT
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adolescents
A Phase II Study of the Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adolescents
Status: Enrolling
Updated: 2/5/2018
Clinical Research Facility
mi
from
Syracuse, UT
Click here to add this to my saved trials
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adolescents
A Phase II Study of the Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adolescents
Status: Enrolling
Updated:  2/5/2018
Clinical Research Facility
mi
from
West Haven, UT
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adolescents
A Phase II Study of the Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adolescents
Status: Enrolling
Updated: 2/5/2018
Clinical Research Facility
mi
from
West Haven, UT
Click here to add this to my saved trials
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adolescents
A Phase II Study of the Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adolescents
Status: Enrolling
Updated:  2/5/2018
Clinical Research Facility
mi
from
West Jordan, UT
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adolescents
A Phase II Study of the Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adolescents
Status: Enrolling
Updated: 2/5/2018
Clinical Research Facility
mi
from
West Jordan, UT
Click here to add this to my saved trials
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adolescents
A Phase II Study of the Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adolescents
Status: Enrolling
Updated:  2/5/2018
Clinical Research Facility
mi
from
Charlottesville, VA
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adolescents
A Phase II Study of the Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adolescents
Status: Enrolling
Updated: 2/5/2018
Clinical Research Facility
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adolescents
A Phase II Study of the Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adolescents
Status: Enrolling
Updated:  2/5/2018
Clinical Research Facility
mi
from
Midlothian, VA
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adolescents
A Phase II Study of the Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adolescents
Status: Enrolling
Updated: 2/5/2018
Clinical Research Facility
mi
from
Midlothian, VA
Click here to add this to my saved trials
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adolescents
A Phase II Study of the Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adolescents
Status: Enrolling
Updated:  2/5/2018
Clinical Research Facility
mi
from
Spokane, WA
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adolescents
A Phase II Study of the Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adolescents
Status: Enrolling
Updated: 2/5/2018
Clinical Research Facility
mi
from
Spokane, WA
Click here to add this to my saved trials
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adolescents
A Phase II Study of the Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adolescents
Status: Enrolling
Updated:  2/5/2018
Clinical Research Facility
mi
from
Spokane, WA
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adolescents
A Phase II Study of the Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adolescents
Status: Enrolling
Updated: 2/5/2018
Clinical Research Facility
mi
from
Spokane, WA
Click here to add this to my saved trials
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adolescents
A Phase II Study of the Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adolescents
Status: Enrolling
Updated:  2/5/2018
Research site
mi
from
San Juan,
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adolescents
A Phase II Study of the Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adolescents
Status: Enrolling
Updated: 2/5/2018
Research site
mi
from
San Juan,
Click here to add this to my saved trials
The Effect of Prophylactic Antipyretics on Immune Responses and Fever After 2014-2015 and 2015-2016 Inactivated Influenza Vaccine
Clinical Immunization Safety Assessment (CISA): A Study to Assess the Effect of Prophylactic Antipyretics on Immune Responses and Fever After 2014-2015 and 2015-2016 Inactivated Influenza Vaccine (IIV) Administered to Children 6 Through 47 Months of Age
Status: Enrolling
Updated:  2/5/2018
Duke University Health System
mi
from
Durham, NC
The Effect of Prophylactic Antipyretics on Immune Responses and Fever After 2014-2015 and 2015-2016 Inactivated Influenza Vaccine
Clinical Immunization Safety Assessment (CISA): A Study to Assess the Effect of Prophylactic Antipyretics on Immune Responses and Fever After 2014-2015 and 2015-2016 Inactivated Influenza Vaccine (IIV) Administered to Children 6 Through 47 Months of Age
Status: Enrolling
Updated: 2/5/2018
Duke University Health System
mi
from
Durham, NC
Click here to add this to my saved trials
Study of a Quadrivalent Meningococcal Conjugate Vaccine in Subjects Aged 56 and Older
Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine Administered in Subjects 56 Years of Age and Older
Status: Enrolling
Updated:  2/5/2018
Clinical Research Facility
mi
from
Chandler, AZ
Study of a Quadrivalent Meningococcal Conjugate Vaccine in Subjects Aged 56 and Older
Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine Administered in Subjects 56 Years of Age and Older
Status: Enrolling
Updated: 2/5/2018
Clinical Research Facility
mi
from
Chandler, AZ
Click here to add this to my saved trials
Study of a Quadrivalent Meningococcal Conjugate Vaccine in Subjects Aged 56 and Older
Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine Administered in Subjects 56 Years of Age and Older
Status: Enrolling
Updated:  2/5/2018
Clinical Research Facility
mi
from
Scottsdale, AZ
Study of a Quadrivalent Meningococcal Conjugate Vaccine in Subjects Aged 56 and Older
Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine Administered in Subjects 56 Years of Age and Older
Status: Enrolling
Updated: 2/5/2018
Clinical Research Facility
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Study of a Quadrivalent Meningococcal Conjugate Vaccine in Subjects Aged 56 and Older
Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine Administered in Subjects 56 Years of Age and Older
Status: Enrolling
Updated:  2/5/2018
Clinical Research Facility
mi
from
Denver, CO
Study of a Quadrivalent Meningococcal Conjugate Vaccine in Subjects Aged 56 and Older
Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine Administered in Subjects 56 Years of Age and Older
Status: Enrolling
Updated: 2/5/2018
Clinical Research Facility
mi
from
Denver, CO
Click here to add this to my saved trials
Study of a Quadrivalent Meningococcal Conjugate Vaccine in Subjects Aged 56 and Older
Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine Administered in Subjects 56 Years of Age and Older
Status: Enrolling
Updated:  2/5/2018
Clinical Research Facility
mi
from
Milford, CT
Study of a Quadrivalent Meningococcal Conjugate Vaccine in Subjects Aged 56 and Older
Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine Administered in Subjects 56 Years of Age and Older
Status: Enrolling
Updated: 2/5/2018
Clinical Research Facility
mi
from
Milford, CT
Click here to add this to my saved trials
Study of a Quadrivalent Meningococcal Conjugate Vaccine in Subjects Aged 56 and Older
Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine Administered in Subjects 56 Years of Age and Older
Status: Enrolling
Updated:  2/5/2018
Clinical Research Facility
mi
from
Edina, MN
Study of a Quadrivalent Meningococcal Conjugate Vaccine in Subjects Aged 56 and Older
Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine Administered in Subjects 56 Years of Age and Older
Status: Enrolling
Updated: 2/5/2018
Clinical Research Facility
mi
from
Edina, MN
Click here to add this to my saved trials
Study of a Quadrivalent Meningococcal Conjugate Vaccine in Subjects Aged 56 and Older
Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine Administered in Subjects 56 Years of Age and Older
Status: Enrolling
Updated:  2/5/2018
Clinical Research Facility
mi
from
Saint Louis, MO
Study of a Quadrivalent Meningococcal Conjugate Vaccine in Subjects Aged 56 and Older
Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine Administered in Subjects 56 Years of Age and Older
Status: Enrolling
Updated: 2/5/2018
Clinical Research Facility
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Study of a Quadrivalent Meningococcal Conjugate Vaccine in Subjects Aged 56 and Older
Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine Administered in Subjects 56 Years of Age and Older
Status: Enrolling
Updated:  2/5/2018
Clinical Research Facility
mi
from
Columbus, OH
Study of a Quadrivalent Meningococcal Conjugate Vaccine in Subjects Aged 56 and Older
Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine Administered in Subjects 56 Years of Age and Older
Status: Enrolling
Updated: 2/5/2018
Clinical Research Facility
mi
from
Columbus, OH
Click here to add this to my saved trials
Study of a Quadrivalent Meningococcal Conjugate Vaccine in Subjects Aged 56 and Older
Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine Administered in Subjects 56 Years of Age and Older
Status: Enrolling
Updated:  2/5/2018
Clinical Research Facility
mi
from
Anderson, SC
Study of a Quadrivalent Meningococcal Conjugate Vaccine in Subjects Aged 56 and Older
Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine Administered in Subjects 56 Years of Age and Older
Status: Enrolling
Updated: 2/5/2018
Clinical Research Facility
mi
from
Anderson, SC
Click here to add this to my saved trials
Study of a Quadrivalent Meningococcal Conjugate Vaccine in Subjects Aged 56 and Older
Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine Administered in Subjects 56 Years of Age and Older
Status: Enrolling
Updated:  2/5/2018
Clinical Research Facility
mi
from
Murray, UT
Study of a Quadrivalent Meningococcal Conjugate Vaccine in Subjects Aged 56 and Older
Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine Administered in Subjects 56 Years of Age and Older
Status: Enrolling
Updated: 2/5/2018
Clinical Research Facility
mi
from
Murray, UT
Click here to add this to my saved trials
Study of a Quadrivalent Meningococcal Conjugate Vaccine in Subjects Aged 56 and Older
Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine Administered in Subjects 56 Years of Age and Older
Status: Enrolling
Updated:  2/5/2018
Clinical Research Facility
mi
from
Salt Lake City, UT
Study of a Quadrivalent Meningococcal Conjugate Vaccine in Subjects Aged 56 and Older
Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine Administered in Subjects 56 Years of Age and Older
Status: Enrolling
Updated: 2/5/2018
Clinical Research Facility
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Study of a Quadrivalent Meningococcal Conjugate Vaccine in Subjects Aged 56 and Older
Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine Administered in Subjects 56 Years of Age and Older
Status: Enrolling
Updated:  2/5/2018
Clinical Research Facility
mi
from
West Jordan, UT
Study of a Quadrivalent Meningococcal Conjugate Vaccine in Subjects Aged 56 and Older
Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine Administered in Subjects 56 Years of Age and Older
Status: Enrolling
Updated: 2/5/2018
Clinical Research Facility
mi
from
West Jordan, UT
Click here to add this to my saved trials
Study of a Quadrivalent Meningococcal Conjugate Vaccine in Subjects Aged 56 and Older
Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine Administered in Subjects 56 Years of Age and Older
Status: Enrolling
Updated:  2/5/2018
Clinical Research Facility
mi
from
Charlottesville, VA
Study of a Quadrivalent Meningococcal Conjugate Vaccine in Subjects Aged 56 and Older
Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine Administered in Subjects 56 Years of Age and Older
Status: Enrolling
Updated: 2/5/2018
Clinical Research Facility
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Donor T Cells After Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies
Pilot Study of Prophylactic Dose-Escalation Donor Lymphocyte Infusion After T Cell Depleted Allogeneic Stem Cell Transplant in High Risk Patients With Hematologic Malignancies
Status: Enrolling
Updated:  2/6/2018
University of Chicago Comprehensive Cancer Center
mi
from
Chicago, IL
Donor T Cells After Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies
Pilot Study of Prophylactic Dose-Escalation Donor Lymphocyte Infusion After T Cell Depleted Allogeneic Stem Cell Transplant in High Risk Patients With Hematologic Malignancies
Status: Enrolling
Updated: 2/6/2018
University of Chicago Comprehensive Cancer Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Sutezolid
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Sutezolid in Healthy Adult Subjects
Status: Enrolling
Updated:  2/6/2018
Worldwide Clinical Trials
mi
from
San Antonio, TX
Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Sutezolid
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Sutezolid in Healthy Adult Subjects
Status: Enrolling
Updated: 2/6/2018
Worldwide Clinical Trials
mi
from
San Antonio, TX
Click here to add this to my saved trials
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Adults 56 Years and Older
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Adults Age 56 Years and Older
Status: Enrolling
Updated:  2/6/2018
Clinical Research Facility
mi
from
Chandler, AZ
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Adults 56 Years and Older
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Adults Age 56 Years and Older
Status: Enrolling
Updated: 2/6/2018
Clinical Research Facility
mi
from
Chandler, AZ
Click here to add this to my saved trials
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Adults 56 Years and Older
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Adults Age 56 Years and Older
Status: Enrolling
Updated:  2/6/2018
Clinical Research Facility
mi
from
Anaheim, CA
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Adults 56 Years and Older
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Adults Age 56 Years and Older
Status: Enrolling
Updated: 2/6/2018
Clinical Research Facility
mi
from
Anaheim, CA
Click here to add this to my saved trials
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Adults 56 Years and Older
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Adults Age 56 Years and Older
Status: Enrolling
Updated:  2/6/2018
Clinical Research Facility
mi
from
San Diego, CA
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Adults 56 Years and Older
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Adults Age 56 Years and Older
Status: Enrolling
Updated: 2/6/2018
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Adults 56 Years and Older
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Adults Age 56 Years and Older
Status: Enrolling
Updated:  2/6/2018
Clinical Research Facility
mi
from
Waterbury, CT
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Adults 56 Years and Older
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Adults Age 56 Years and Older
Status: Enrolling
Updated: 2/6/2018
Clinical Research Facility
mi
from
Waterbury, CT
Click here to add this to my saved trials
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Adults 56 Years and Older
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Adults Age 56 Years and Older
Status: Enrolling
Updated:  2/6/2018
Clinical Research Facility
mi
from
Clearwater, FL
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Adults 56 Years and Older
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Adults Age 56 Years and Older
Status: Enrolling
Updated: 2/6/2018
Clinical Research Facility
mi
from
Clearwater, FL
Click here to add this to my saved trials
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Adults 56 Years and Older
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Adults Age 56 Years and Older
Status: Enrolling
Updated:  2/6/2018
Clinical Research Facility
mi
from
DeLand, FL
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Adults 56 Years and Older
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Adults Age 56 Years and Older
Status: Enrolling
Updated: 2/6/2018
Clinical Research Facility
mi
from
DeLand, FL
Click here to add this to my saved trials
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Adults 56 Years and Older
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Adults Age 56 Years and Older
Status: Enrolling
Updated:  2/6/2018
Clinical Research Facility
mi
from
Jacksonville, FL
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Adults 56 Years and Older
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Adults Age 56 Years and Older
Status: Enrolling
Updated: 2/6/2018
Clinical Research Facility
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Adults 56 Years and Older
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Adults Age 56 Years and Older
Status: Enrolling
Updated:  2/6/2018
Clinical Research Facility
mi
from
Ponte Vedra, FL
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Adults 56 Years and Older
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Adults Age 56 Years and Older
Status: Enrolling
Updated: 2/6/2018
Clinical Research Facility
mi
from
Ponte Vedra, FL
Click here to add this to my saved trials
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Adults 56 Years and Older
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Adults Age 56 Years and Older
Status: Enrolling
Updated:  2/6/2018
Clinical Research Facility
mi
from
Port Orange, FL
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Adults 56 Years and Older
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Adults Age 56 Years and Older
Status: Enrolling
Updated: 2/6/2018
Clinical Research Facility
mi
from
Port Orange, FL
Click here to add this to my saved trials
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Adults 56 Years and Older
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Adults Age 56 Years and Older
Status: Enrolling
Updated:  2/6/2018
Clinical Research Facility
mi
from
West Palm Beach, FL
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Adults 56 Years and Older
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Adults Age 56 Years and Older
Status: Enrolling
Updated: 2/6/2018
Clinical Research Facility
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Adults 56 Years and Older
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Adults Age 56 Years and Older
Status: Enrolling
Updated:  2/6/2018
Clinical Research Facility
mi
from
Lenexa, KA
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Adults 56 Years and Older
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Adults Age 56 Years and Older
Status: Enrolling
Updated: 2/6/2018
Clinical Research Facility
mi
from
Lenexa, KA
Click here to add this to my saved trials
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Adults 56 Years and Older
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Adults Age 56 Years and Older
Status: Enrolling
Updated:  2/6/2018
Clinical Research Facility
mi
from
Newton, KA
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Adults 56 Years and Older
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Adults Age 56 Years and Older
Status: Enrolling
Updated: 2/6/2018
Clinical Research Facility
mi
from
Newton, KA
Click here to add this to my saved trials
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Adults 56 Years and Older
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Adults Age 56 Years and Older
Status: Enrolling
Updated:  2/6/2018
Clinical Research Facility
mi
from
Wichita, KA
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Adults 56 Years and Older
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Adults Age 56 Years and Older
Status: Enrolling
Updated: 2/6/2018
Clinical Research Facility
mi
from
Wichita, KA
Click here to add this to my saved trials
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Adults 56 Years and Older
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Adults Age 56 Years and Older
Status: Enrolling
Updated:  2/6/2018
Clinical Research Facility
mi
from
Elkridge, MD
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Adults 56 Years and Older
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Adults Age 56 Years and Older
Status: Enrolling
Updated: 2/6/2018
Clinical Research Facility
mi
from
Elkridge, MD
Click here to add this to my saved trials
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Adults 56 Years and Older
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Adults Age 56 Years and Older
Status: Enrolling
Updated:  2/6/2018
Clinical Research Facility
mi
from
Quincy, MA
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Adults 56 Years and Older
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Adults Age 56 Years and Older
Status: Enrolling
Updated: 2/6/2018
Clinical Research Facility
mi
from
Quincy, MA
Click here to add this to my saved trials
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Adults 56 Years and Older
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Adults Age 56 Years and Older
Status: Enrolling
Updated:  2/6/2018
Clinical Research Facility
mi
from
Troy, MI
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Adults 56 Years and Older
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Adults Age 56 Years and Older
Status: Enrolling
Updated: 2/6/2018
Clinical Research Facility
mi
from
Troy, MI
Click here to add this to my saved trials